Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Clovis Oncology (CLVS) News Today

Clovis Oncology logo

CLVS Latest News

Clovis Chamber names new Retail Rockstar
Cancer Horoscope
City of Clovis hosts tree lighting ceremony
Wing commander receives key to the city of Clovis
Clovis East High School
Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Analysts Holding As Pfizer Waits On Two Phase 3 Studies (CLVS)
Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.
CLVS.O
CLVSQ Clovis Oncology, Inc.
Clovis Oncology
Boulder drugmaker Clovis Oncology files for bankruptcy
Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
Cancer Focused Clovis Oncology Files For Bankruptcy
U.S. drugmaker Clovis files for Chapter 11 bankruptcy
Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning
Get Clovis Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVS and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLVS Media Mentions By Week

CLVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLVS
News Sentiment

0.00

0.92

Average
Medical
News Sentiment

CLVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLVS Articles
This Week

0

0

CLVS Articles
Average Week

Get the Latest News and Ratings for CLVS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Clovis Oncology and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CLVS) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners